[Table_Title] 加盟态黄金珠宝领军品牌 2025 年 06 月 24 日 公司研究 联系人 ： 丁婧欣 S0350124040002 ——周六福（06168）招股书解读 投资要点: 国海证券研究所 请务必阅读正文后免责条款部分 研究所： 证券分析师： 马川琪 S0350523050001 macq@ghzq.com.cn 证券分析师： 廖小慧 S0350524080002 liaoxh@ghzq.com.cn dingjx@ghzq.com.cn 周六福创立于 2004 年，是聚焦下沉市场的规模化黄金珠宝品牌。公 司发展初期率先布局全国三线及其他低线城市与一二线城郊，后逐 步向高线城市拓展。据公司招股书，截至 2024 年 12 月 31 日，周 六福线下门店共 4129 家，按中国线下门店数目计，在中国所有珠宝 品牌中排名第五。2022-2024 年，公司营收从 31.02 亿元增至 57.18 亿元，CAGR 为 35.8%，远超行业平均 2.7%；净利润从 5.75 亿元 增至 7.06 亿元，CAGR 为 10.8%。公司股权结构高度集中，截至 2025 年 5 月 25 日，李伟柱先生、 ...

为普及金融知识，帮助幼儿从小树立正确的金钱观和理财意识，近日，民生银行济宁任城支行联合济宁 市某幼儿园开展了一场别开生面的"小小银行家"暨"爱护人民币 了解人民币"主题宣传活动。 为了让孩子们更直观地了解银行业务，支行特别设置了"小小银行家"职业体验环节。在工作人员的指导 下，孩子们轮流扮演"柜员"和"客户"，模拟存取款、点钞等基础业务操作。点钞比赛环节更是将活动推 向高潮，孩子们认真模仿银行阿姨的点钞动作，虽然手法稚嫩，但专注的模样赢得了在场老师和家长的 阵阵掌声。通过角色扮演，孩子们不仅锻炼了动手能力，还感受到银行工作的严谨与责任。 人民币是国家的名片，爱护人民币是每个公民的责任。活动中，工作人员通过展示破损、涂鸦的人民币 案例，向孩子们讲解随意毁坏人民币的危害，并示范正确的使用和保存方法。"不能乱画、乱折，要像 爱护眼睛一样爱护钱币！"孩子们齐声承诺。随后，在银行员工的带领下，大家共同完成了"爱护人民 币"主题手绘海报，用彩笔描绘出自己对人民币的理解和珍视。 活动结束后，民生银行济宁任城支行还为每位小朋友颁发了"小小银行家"荣誉证书，并赠送了金融知识 绘本。幼儿园老师表示，这样的实践活动弥补了课堂教育的 ...

"以前总觉得非法集资离自己很远，今天听了讲解才知道，原来骗子手段这么多！"一位参与活动的市民 感慨道。不少群众表示，通过此次活动，不仅学到了实用的防骗技巧，还对合法理财有了更清晰的认 识。 民生银行济宁任城支行相关负责人表示，未来将持续加强与政府及相关部门的合作，常态化开展金融知 识普及活动，切实履行金融机构的社会责任。此次"守住钱袋子 护好幸福家"宣传活动，不仅增强了市 民的金融安全意识，也展现了民生银行济宁任城支行在维护地方金融稳定中的积极作用。下一步，该支 行将继续深化与监管部门的协作，创新宣传方式，为构建和谐健康的金融环境贡献力量。 济宁市金融办相关负责人表示："非法集资严重扰乱金融秩序，侵害群众利益。此次联合宣传活动旨在 提高市民的识别能力和风险防范意识，形成全社会共同抵制非法集资的良好氛围。"中国人民银行济宁 市分行工作人员则从金融监管角度，强调了合法投资渠道的重要性，提醒市民选择正规金融机构进行理 财。 为使宣传更接地气，活动采用了互动问答、情景模拟等生动形式，吸引了不少市民驻足参与。民生银行 济宁任城支行的工作人员还通过真实案例剖析，向市民揭示非法集资"高额回报""保本保息"等话术背后 的陷阱 ...

Core Insights - BriaCell Therapeutics Corp. has received a positive recommendation from the independent Data Safety Monitoring Board (DSMB) for its pivotal Phase 3 study of Bria-IMT combined with immune checkpoint inhibitors in metastatic breast cancer [1][2][6] - This marks the third consecutive positive review from the DSMB, affirming the favorable safety profile of the treatment [2][3] - The study is being conducted under the Fast Track designation by the US FDA, indicating a significant unmet medical need in the patient population [2][6] Company Overview - BriaCell is a clinical-stage biotechnology company focused on developing novel immunotherapies aimed at transforming cancer care [1][3] - The company is currently advancing its Bria-IMT treatment, which has shown promising safety and tolerability in clinical trials [3]

Core Insights - BTQ Technologies Corp. has introduced the Quantum Stablecoin Settlement Network (QSSN), aimed at securing stablecoin platforms against quantum computing cybersecurity threats [2][5][7] - The stablecoin market has surpassed $225 billion, with increasing institutional demand and regulatory clarity driving adoption [5][7][16] - The QSSN framework is designed to help banks and digital asset platforms issue and manage stablecoins while complying with emerging quantum security mandates [8][12][18] Company Overview - BTQ Technologies is a global quantum technology company focused on securing mission-critical networks and has a decade-long collaboration with NIST to propose technical standards for quantum security [2][18] - The company aims to position itself as a critical technology provider for secure and scalable digital finance, particularly in the stablecoin and tokenized asset markets [5][12][19] Market Context - The stablecoin sector is rapidly evolving, with governments introducing new requirements to ensure long-term security in response to quantum computing advancements [7][8][16] - The GENIUS Act is advancing through Congress, seeking to establish federal guidelines for fiat-backed stablecoins, reinforcing the need for secure digital currency infrastructure [17][18] Technological Solution - QSSN will enable a quantum-secure version of JPMorgan's proposed USD deposit token (JPMD), allowing compliance with U.S. federal cybersecurity standards without altering existing token standards [5][9][10] - The framework enhances security for core stablecoin functions while maintaining compatibility with existing payment systems and compliance processes [12][15] Future Outlook - BTQ's QSSN is positioned to capitalize on the growing demand for quantum-proof financial infrastructure, providing a scalable, revenue-generating platform for stablecoin issuance and management [5][19] - The anticipated approval of the GENIUS Act will formalize digitized money as part of the financial system, creating further opportunities for BTQ and the stablecoin market [17][18]

WEST PALM BEACH, Fla., June 24, 2025 (GLOBE NEWSWIRE) -- Sunrise Realty Trust, Inc. (“SUNS”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced that it will release its financial results for the second quarter ending June 30, 2025 on Thursday, August 7th, 2025 before market open. Management will review SUNS’ financial results at 10:00 am ET via webcast available on the Investor Relations website at ir.sunriserealtytrust.com. Participants are also invited t ...

Comprehensive restructuring eliminates the potential issuance of up to 1.5 billion shares of common stock Plus Therapeutics files a request to withdraw the related resale registration statement with the SEC HOUSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announces a comprehensive restructuring of its pre ...

Initiative aims to expand and encourage philanthropy to help patients with retinal diseases afford their medicationsTARRYTOWN, N.Y., June 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the launch of a pioneering matching program for donations to Good Days, an independent national non-profit charitable organization, to support Good Days’ Retinal Vascular and Neovascular Disease Fund. Through this initiative, Regeneron has committed to matching donations up to a to ...

PARIS, June 24, 2025 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) is proud to announce that it has been recognized with three awards at the 2025 edition of Airbus’ Supply Chain & Quality Improvement Program (SQIP), held in early June. The program honors suppliers that consistently deliver excellence in their quality & delivery performance and industrial maturity. Constellium’s facilities in Issoire and Montreuil-Juigné were honored for their significant contributions to Airbus’ supply chain: Issoire – Ac ...

Achieved statistical significance on primary endpoint at week 16 for mean percent change in EASI score from baseline for all rezpegaldesleukin arms versus placeboAchieved statistical significance for key secondary endpoints at week 16 of disease reduction, including EASI-75, EASI-90, Itch NRS, vIGA-AD and BSARapid onset of EASI reduction and magnitude of itch improvement show potential differentiation of this novel regulatory T-cell mechanism as a first and best-in-class immune-modulator Robust dose-depende ...